MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 05-16-2026
Marinus Pharmaceuticals Total Inventories 2011-2026 | MRNS
Annual Total Inventories Marinus Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.41 M | 77 K | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.41 M | 77 K | 1.24 M |
Quarterly Total Inventories Marinus Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.72 M | 4.87 M | 5.78 M | 2.41 M | 2.74 M | 2.67 M | 37 K | 77 K | 104 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.72 M | 37 K | 2.82 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Happiness Biotech Group Limited
HAPP
|
653 K | - | 1.35 % | $ 17.8 M |  China |
 |
Esperion Therapeutics
ESPR
|
105 M | $ 3.14 | 0.32 % | $ 653 M |  USA |
 |
Eton Pharmaceuticals
ETON
|
15.4 M | $ 35.15 | 2.02 % | $ 946 M | USA |
 |
Berkeley Lights
BLI
|
18.9 M | - | -7.31 % | $ 87 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.65 | 1.54 % | $ 439 M |  Britain |
 |
Heron Therapeutics
HRTX
|
92.7 M | $ 0.85 | 0.96 % | $ 142 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
1.38 M | - | -4.36 % | $ 27 M | USA |
 |
Incyte Corporation
INCY
|
101 M | $ 96.88 | -0.21 % | $ 18.9 B | USA |
 |
Ionis Pharmaceuticals
IONS
|
10 M | $ 75.36 | 0.39 % | $ 12.1 B | USA |
 |
Anika Therapeutics
ANIK
|
18.8 M | $ 14.91 | -1.52 % | $ 214 M | USA |
 |
Coherus BioSciences
CHRS
|
3.17 M | $ 1.55 | 2.65 % | $ 182 M | USA |
 |
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 20.77 | 1.47 % | $ 2.64 B | USA |